Developer of AI-driven non-viral gene delivery systems. It uses artificial intelligence to design and synthesize polymer nanoparticles for targeted and safe gene therapy. These nanoparticles offer advantages over traditional viral vectors and lipid nanoparticles, addressing a major hurdle in gene therapy. The platform combines high-throughput synthesis, biology, materials science, and artificial intelligence to create programmable and effective delivery vehicles for a wide range of genetic medicines.
← All startups
Nanite
SeedDeveloper of AI-driven non-viral gene delivery systems. It uses artificial intelligence to design and synthesize polymer nanoparticles for targeted and safe gene therapy. These nanoparticles offer advantages over traditional viral vectors and lipid nanoparticles, addressing a major hurdle in gene therapy. The platform combines high-throughput synthesis, biology, materials science, and artificial intelligence to…
About
Institutional investors
Zetta Venture PartnersArkitekt VenturesCystic Fibrosis FoundationGatesHHSCivilization Ventures
Latest coverage
📰 Latest funding news — recent raises and deal signals across the ecosystem.
Investor directory
🗂️ Browse all funds in our directory — active VCs and growth investors by stage and sector.